In an open-label, randomized trial, 44 Vietnamese children with diphtheria were given penicillin therapy (intramuscular benzylpenicillin, 50,000 U/[kgrd] for 5 days and then oral penicillin, 50 mg/ [kgrd] for 5 days), and 42 were given erythromycin therapy (50 mg/[kgrd] orally for 10 days). There were no differences in times to membrane clearance or bacteriologic clearance, but median times to fever clearance were 27 hours (95% confidence interval [CI], 19 -30; range, 0 -124 hours) for penicillin recipients and 46 hours (95% CI, 34 -54; range, 0 -148 hours) for erythromycin recipients (P Å .0004). In the penicillin group, acute treatment failed for one patient, and one patient relapsed. Three patients in the penicillin group developed diphtheritic myocarditis as evidenced by abnormal electrocardiograms. Erythromycin did not cause prolongation of the QT interval corrected for heart rate. Cultures of specimens from 15 patients (17.4%) were positive for toxigenic Corynebacterium diphtheriae. All isolates were susceptible to penicillin, but four isolates (27%), all of which were from patients who received penicillin treatment, were resistant to erythromycin (minimum inhibitory concentrations, ú64 mg/L). Penicillin is recommended as first-line treatment for diphtheria in Vietnam.
Diphtheria remains an important public health problem in
shown to be proarrhythmic, especially in patients with concurrent cardiac disease [6] . Whether drug-induced arrhythmias much of the developing world and has undergone a recent resurgence in eastern Europe and the former Soviet Union [1] .
occur during erythromycin treatment of diphtheria is not known. The only clinical trial that set out to compare penicillin In southern Vietnam, ú100 cases per year still occur, despite a vaccination coverage rate of ú90% [2] . Infection with toxiand erythromycin in the treatment of acute diphtheria was stopped early because of a high incidence of thrombophlebitis genic Corynebacterium diphtheriae may result in widespread toxin-mediated damage, particularly to the heart (diphtheritic in patients receiving parenteral erythromycin [7] . To our knowledge, there have been no other comparisons of these myocarditis), kidneys, and nervous system. The incidence of diphtheritic myocarditis following nasopharyngeal diphtheria antibiotics. In view of these uncertainties, we conducted a prospective, open-label, randomized trial of erythromycin and penis 10% -20%, and the associated mortality rate is Ç50% [3] . Diphtheria is treated with both antitoxin and antibiotics. Antiicillin in the treatment of Vietnamese children with diphtheria. toxin neutralizes unbound toxin, and antibiotics prevent further toxin production and spread of the bacterium. Methods C. diphtheriae is susceptible to a wide range of antibiotics [4] , and currently both penicillin and erythromycin are recomThis study was conducted between June 1995 and May 1996 mended as treatment of diphtheria by the World Health Organion the diphtheria ward of the Centre for Tropical Diseases, zation (WHO) [5] . However, erythromycin has recently been Cho Quan Hospital, Ho Chi Minh City, Vietnam (a referral hospital for diphtheria patients from southern Vietnam). Children (younger than 16 years of age) for whom diphtheria was clinically diagnosed and whose parents or guardians gave in-
Laboratory Procedures
cases of more extensive pharyngeal disease, there is always extensive swelling and congestion. At the time of admission, blood specimens were obtained Patients for whom there was diagnostic uncertainty (i.e., for determination of hematocrit, differential WBC count, and those with acute pharyngitis but without clear membrane forplatelet count, and for examination for malarial parasites. Four mation) were not included in this study. Moribund patients sterile swab specimens were obtained at admission: one swab (those with shock or cyanosis) and patients who were known specimen from each tonsil and one swab specimen from each to be allergic to penicillin or erythromycin were also excluded nostril. In addition, a set of these four swab specimens was from the study. obtained on days 2, 5, 12, and 24, and 1 month after discharge. Swabs were inoculated onto 5% sheep blood agar and Hoyle's tellurite agar with 5% lysed sheep blood (Oxoid, Basingstoke, Hants, United Kingdom). Plates were incubated in Treatment room air at 37ЊC for 48 hours. Suspicious colonies were identified as C. diphtheriae on the basis of pyrazinamidase and cystiAs soon as the diagnosis of diphtheria was made clinically nase tests [9] , and identification was confirmed by using a (i.e., at the time of admission), patients received an intramuscucommercial kit (API Coryne, Basingstoke). Toxigenicity was lar injection of 20,000 -60,000 IU of diphtheria antitoxin determined by means of the Elek immunoprecipitation test [9] . (Pasteur Institute, Nha Trang, Vietnam) in accordance with Antimicrobial susceptibilities were determined at the time of WHO guidelines [5] . Patients with severe swelling of the tonisolation by the modified Kirby-Bauer method with use of disks sils or pharynx were also given intravenous hydrocortisone containing ampicillin (10 mg), chloramphenicol (30 mg), horse blood, and plates were incubated at 37ЊC for 24 hours. for 10 days). Treatment codes were contained in serially num-A single colony of each isolate was subcultured into brainbered sealed envelopes that were opened only after the patient heart infusion broth supplemented with yeast extract and Tween was enrolled into the study.
80 (Remel, Lenexa, KS), and the suspensions were incubated for 18 -20 hours at 37ЊC. A multipoint inoculator was used to apply 1-mL inocula (10 5 -10 6 cfu) of each strain to the surface
Assessment of Patients
of Mueller-Hinton agar containing saponin-lysed sheep blood (5%), and serial twofold dilutions of each of the antibiotics A detailed medical history was obtained and a clinical examiwere included. nation performed by a member of the study team at the time of admission. A history of previous treatment was obtained,
Evaluation of Treatment Response
although it was not possible to identify the antibiotics used Time to bacteriologic clearance was defined as the time from with confidence. All details were recorded on standard forms. the onset of treatment until all four swabs in a set were negative Axillary temperature and other vital signs were recorded every for C. diphtheriae. Time to membrane clearance was the time 6 hours. Patients were examined daily until discharge.
until the membrane cleared from the nasopharynx, and time to Serial 12-lead electrocardiograms were taken on alternate fever clearance was the time until the temperature fell to days during hospitalization from day 1 to day 10 and then õ37.5ЊC for at least 24 hours. The persistence of the membrane weekly until discharge. Electrocardiography was performed or isolation of C. diphtheriae from swabs at the end of treatment more frequently for patients who developed clinical or electrowas considered an acute treatment failure. A relapse was decardiographic evidence of diphtheritic myocarditis. The QT fined as reappearance of the membrane or reisolation of interval corrected for heart rate (QT c ) was calculated in chest C. diphtheriae. Patients were requested to return to the outpalead 1, which was recorded at a rate of 50 mm/s, by means of tient department 4 weeks after completion of treatment for Bazett's formula (QT c Å QT interval/ RR interval) [8] . From further assessment. our previous experience with penicillin-treated patients at this center, we expected that the average time to membrane clear-
Statistical Analysis
ance would be 3 days. The study was therefore designed to detect an improvement in clearance time of 50%, with 95%
Normally distributed data for the two treatment groups were compared by using the Student's t-test. Data that were not confidence and 80% power.
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09-16-98 11:46:38 cidas UC: CID normally distributed were compared by using the Mann-Whittion revealed quiet heart sounds and cardiac enlargement. All three patients had abnormal electrocardiograms. The first paney U test. Differences between proportions were tested by using the x 2 test with Yates' correction or Fisher's exact test. tient had a long QT c (0.45 second) on day 1 and developed left bundle-branch block on day 2; this heart block lasted 2 Multiple regression analysis was used to investigate the influence of potential confounders on the main outcome variables.
weeks and was associated with further QT c prolongation (up to 0.53 second). The second patient had multiple supraventricular ectopics and occasional ventricular ectopics from day 6 to day Results 13. The third patient had sinus tachycardia (heart rate, 125) and QT c prolongation (0.46 second) on days 6 -8. This patient Demographic, clinical, and laboratory findings for the 86 developed paralysis of the palate with nasal speech on day 22, children (44 randomized to penicillin therapy and 42 randomwhich improved after 2 weeks. ized to erythromycin therapy) who were enrolled in the trial Two other patients in the penicillin group and one patient are shown in table 1. Four children (age, 6 -13 years), including in the erythromycin group, all of whom had no clinical signs a girl with an unrepaired cleft palate, were from one family.
of cardiac disease, developed prolonged QT c (ú0.44 second) There were no significant differences between the two treatduring treatment that resolved. The median QT c at the time of ment groups in terms of characteristics at the time of admission. admission for erythromycin-treated patients was 0.40 second Overall, 49% of patients had a definite history of antibiotic (range, 0.33 -0.44 second), and that for penicillin-treated patherapy before admission to the hospital. tients was 0.39 second (range, 0.33 -0.45 second). The median All patients had tonsillar diphtheria, 61 (71%) of whom had increase in QT c during treatment was 0.03 second for the erytha membrane on both tonsils. In addition, seven children had a romycin group and 0.04 second for the penicillin group membrane on the pharyngeal wall and uvula. One of these (P Å .15). The QT c was longer for all patients during treatment patients had a nasal membrane and a shallow 5-mm ulcer on and in the convalescent period than at the time of admission. the philtrum of the upper lip. Treatment with antitoxin and
The median QT c at the time of admission was 0.39 second antibiotics was started at the time of admission in all cases.
(range 0.33 -0.45 second); during treatment, it was 0.42 second C. diphtheriae was isolated from 15 children (17.4%) at the (range 0.36 -0.53 second) (P õ .0001), and during convalestime of admission. In all culture-positive cases, there was at cence, it was 0.42 second (range, 0.36 -0.48 second) least one positive throat swab; positive nose swabs also were (P õ .0001). found in three of these cases.
Microbiology Complications
Three patients in the penicillin group developed clinical All 15 isolates were susceptible to penicillin, ampicillin, ceftriaxone, and rifampin, but five (33%) were resistant to one signs of myocarditis, all within the first week of illness. brane, after which he named the disease (Greek diphthera: leather or hide). In 1888, Roux and Yersin demonstrated that the systemic complications of diphtheria were caused by a toxin and not direct bacterial invasion. With the development erythromycin (MIC, ú64 mg/L); 2 to both erythromycin (MIC, ú64 mg/L) and tetracycline (MIC, 64 mg/L); and 1 to erythroof antitoxin by von Behring and Kitasato in 1890, specific treatment for diphtheria became possible. In the 1930s, the mycin (MIC, ú64 mg/L), tetracycline (MIC, 64 mg/L), and chloramphenicol (MIC, 64 mg/L). All four children from whom sulfonamide antibiotics were used as treatment in addition to antitoxin, and in the 1940s, penicillin became the standard erythromycin-resistant strains of C. diphtheriae were isolated were randomized to the penicillin group.
antimicrobial treatment for diphtheria [11] . Erythromycin, the prototype macrolide antibiotic, was discovered in 1952 [12] . Erythromycin has better in vitro activity
Response to Treatment against C. diphtheriae than penicillin (MIC of erythromycin, 0.025 -0.05 mg/L) [10, 13], and it is currently endorsed as a All 86 patients completed the trial. Responses to treatment are shown in table 2. The median time to fever clearance was safe alternative to penicillin by the WHO [5] . It is considered by some investigators to be the treatment of choice. Cardiac significantly shorter for the penicillin-treated patients (27 hours [95% CI, 19 -30; range, 0 -124 hours]) than for the erythromyside effects of erythromycin were first reported in the 1980s [14] . The drug has electrophysiological effects similar to those cin-treated patients (46 hours [95% CI, 34 -54; range, 0 -148 hours]) (P Å .0004). In a multiple regression model, the relaof class Ia and class III antiarrhythmic drugs, prolonging ventricular repolarization (QT interval) and occasionally leading tionship of fever clearance to antibiotic treatment remained significant (P Å .001) after controlling for hydrocortisone adto ventricular arrhythmias (including torsades de pointes) [6] . These effects are usually reported in association with high-dose ministration. There were no serious side effects of the drugs in either group. However, penicillin was better tolerated: eight intravenous infusions of erythromycin but have also occurred during oral therapy [15, 16] . Patients with underlying cardiac erythromycin recipients (19%) complained of gastrointestinal disturbances (nausea, vomiting, abdominal pain, and diarrhea), disease are more likely to suffer these cardiac adverse effects. Diphtheritic myocarditis occurs in 10% -20% of patients and one penicillin recipient (2.3%) had nausea (P Å .014).
Penicillin treatment failed for two sisters from one family: with diphtheria and is the usual cause of death. Manifestations of diphtheritic myocarditis include toxic dilated cardiomyopaone acute treatment failure and one relapse. The first patient was a 13-year-old girl with an unrepaired cleft palate. Her thy and conduction disturbances leading to complete heart block [17] . Cardiac complications usually develop during the membrane cleared on day 3, but C. diphtheriae (susceptible to both penicillin and erythromycin) was isolated throughout first 2 weeks of illness. The risk of complications is proportional to the extent of the initial infection; most patients with treatment; she was retreated with a 10-day course of erythromycin (50 mg/[kgrd]), and swabs were negative by day 2 of severe diphtheritic pharyngitis will develop cardiac complications. In the current study, which excluded very severe cases, retreatment. Treatment of the second patient, a 6-year-old girl, was initially successful, but at follow-up, a 5-mm patch of a three patients (3.5%) developed clinical signs of cardiac disease, and a further three patients (3.5%) had electrocardiomembrane was visible in the pharynx. She was asymptomatic, but erythromycin-susceptible C. diphtheriae was isolated; regraphic features only. In five of these patients, the complication developed after treatment began, but only one was randomized treatment with a 10-day course of erythromycin (50 mg/[kgrd]) resulted in eradication of the bacterium. All four siblings and to erythromycin therapy. Treatment with erythromycin did not cause a significant prolongation of QT c when compared with This study showed that penicillin and erythromycin are both effective for the treatment of diphtheria. No clinically penicillin.
In Vietnam, as in many tropical countries, antibiotics are important cardiotoxic effects of erythromycin were demonstrated. However, because of the slower fever clearance and available freely without prescription, and pretreatment before hospital admission is very common. This fact may limit disease higher incidence of gastrointestinal side effects associated with erythromycin therapy and, most importantly, the high progression and also contributes to the low rate of positive cultures.
incidence of resistance, penicillin is recommended as the drug of choice for treatment of patients with diphtheria in Penicillin and erythromycin have been compared once previously in an open-label trial during an outbreak of diphtheria Vietnam. Erythromycin should be reserved for treatment of penicillin-allergic patients. in Texas [7] . Adults and children were randomized to penicillin therapy (intramuscularly for 3 days and then orally for 4 days) or erythromycin therapy (intravenously for 3 days and then orally
